Stay updated on Rilzabrutinib for CSU: H1 Resistant - Clinical Trial
Sign up to get notified when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.

Latest updates to the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page
- Check6 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.3, indicating a new edition of the page. This change reflects minor edits or fixes applied to the page without altering its core content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRecruitment status now shows 'No longer looking for participants', indicating that participant enrollment has closed, while new navigation/help items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' have been added. The label for Intervention/Treatment has been standardized to 'Intervention/Treatment' and the site revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check27 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5 for the page, indicating a minor update to the ClinicalTrials.gov entry. There is no indication that study content or eligibility criteria were modified.SummaryDifference0.0%

- Check48 days agoChange DetectedA new revision label, v3.5.4, has been added to the page, replacing the previous v3.5.3. This change serves as a metadata/versioning update and does not modify the study content presented on the page.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page’s footer site revision was updated from v3.5.2 to v3.5.3, reflecting a website software release rather than any modification to the clinical trial information.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.0%

Stay in the know with updates to Rilzabrutinib for CSU: H1 Resistant - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.